insights_auto
Why is MBIO up ३.०७%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
US$ ०.४१
arrow_upward
+३.०७%(+०.०१२) 1D
US$ ०.४१
arrow_downward
-०.१०% (-०.०००४०)bedtimeAfter hours
Closed: अक्टोबर १२, १६:००:०१ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
US$ ०.४१
High
US$ ०.४४
Low
US$ ०.३८
Mkt. cap
३१.२६ लाख
Avg. vol.
३१.२९ हजार
Volume
५४.३८ हजार
52-wk high
US$ १.६९
52-wk low
US$ ०.३८
EPS
-US$ ०.४६
Beta
२.०९
Shares outstanding
६७.३२ लाख
No. of employees
४
Open
US$ ०.४१
High
US$ ०.४४
Low
US$ ०.३८
Mkt. cap
३१.२६ लाख
Avg. vol.
३१.२९ हजार
Volume
५४.३८ हजार
52-wk high
US$ १.६९
52-wk low
US$ ०.३८
EPS
-US$ ०.४६
Beta
२.०९
Shares outstanding
६७.३२ लाख
No. of employees
४
News stories
From web sources and news partners
https://www.dars.gov.et/
·
१ हप्ता पहिले
MBIO Q4 2024 Earnings: Wider-Than-Expected Loss Per Share Dominates the Quarter - Profit Margin Analysis
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees४
Founded२०१५
HeadquartersWaltham, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Websitemustangbio.com